Bullish option flow detected in Relmada Therapeutics with 2,686 calls trading, 2x expected, and implied vol increasing almost 7 points to 113.06%. Jan-23 12.5 calls and Nov-22 7.5 puts are the most active options, with total volume in those strikes near 2,800 contracts. The Put/Call Ratio is 0.38. Earnings are expected on March 22nd.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on RLMD:
- Rising High: Exclusive talk with financial services firm Safe Harbor
- Here’s What You Missed in Cannabis This Week
- Point72 Asset Management reports 7.3% passive stake in Relmada Therapeutics
- Axsome shares could react positively to Relmada trial failure, says BofA
- Relmada Therapeutics downgraded to Neutral from Buy at Goldman Sachs